Literature DB >> 18660705

Bone-marrow-derived cells and heart repair.

Carlos Clavel1, Catherine M Verfaillie.   

Abstract

PURPOSE OF REVIEW: Cardiovascular diseases are the leading cause of morbidity/mortality in the world. Despite significant progress in cardiovascular medicine, mortality rates have remained steady during the past decade. Therefore, investigators are evaluating novel methods to repair/regenerate the damaged heart. RECENT
FINDINGS: Within the past decade, stem cell therapy strategies have been evaluated for the treatment of cardiovascular diseases. Among all postnatal stem cell compartments, bone marrow has been most extensively studied. Recent studies using bone marrow stem cells have suggested that this approach may have beneficial effects on cardiac function, probably by enhancing new cell formation from endogenous cardiac and endothelial stem/progenitor cells.
SUMMARY: The present review critically assesses the possible beneficial effects of bone-marrow-derived cell therapy in cardiac ischemia, demonstrating benefits through as yet incompletely understood mechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18660705     DOI: 10.1097/MOT.0b013e3282f428d1

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  7 in total

1.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Authors:  Atta Behfar; Satsuki Yamada; Ruben Crespo-Diaz; Jonathan J Nesbitt; Lois A Rowe; Carmen Perez-Terzic; Vinciane Gaussin; Christian Homsy; Jozef Bartunek; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

2.  Insights into neurogenesis and aging: potential therapy for degenerative disease?

Authors:  Robert A Marr; Rosanne M Thomas; Daniel A Peterson
Journal:  Future Neurol       Date:  2010-07-01

3.  Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap.

Authors:  Manuel Mazo; Miriam Araña; Beatriz Pelacho; Felipe Prosper
Journal:  Stem Cells Int       Date:  2012-01-22       Impact factor: 5.443

4.  Telocytes in human epicardium.

Authors:  L M Popescu; C G Manole; M Gherghiceanu; A Ardelean; M I Nicolescu; M E Hinescu; S Kostin
Journal:  J Cell Mol Med       Date:  2010-07-13       Impact factor: 5.310

5.  Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches.

Authors:  L M Popescu; Mihaela Gherghiceanu; C G Manole; Maria Simonetta Faussone-Pellegrini
Journal:  J Cell Mol Med       Date:  2009-04-20       Impact factor: 5.310

6.  Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.

Authors:  Naoki Tajiri; Sandra Acosta; Loren E Glover; Paula C Bickford; Alejandra Jacotte Simancas; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 7.  Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.

Authors:  Naoki Tajiri; Sandra Acosta; Gabriel S Portillo-Gonzales; Daniela Aguirre; Stephanny Reyes; Diego Lozano; Mibel Pabon; Ike Dela Peña; Xunming Ji; Takao Yasuhara; Isao Date; Marianna A Solomita; Ivana Antonucci; Liborio Stuppia; Yuji Kaneko; Cesar V Borlongan
Journal:  Front Cell Neurosci       Date:  2014-08-13       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.